March 15, 2021
Inventiva announces filing of its 2020 Universal Registration Document and 2020 Annual Report on Form 20-F
Daix (France), March 15, 2021 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccha…